Biocartis Group NV
XBRU:BCART

Watchlist Manager
Biocartis Group NV Logo
Biocartis Group NV
XBRU:BCART
Watchlist
Price: 0.29 EUR
Market Cap: €27.2m

Biocartis Group NV
Investor Relations

Biocartis Group NV which engages in the development of oncology molecular diagnostic solutions. The company is headquartered in Malines (Mechelen), Antwerpen and currently employs 619 full-time employees. The company went IPO on 2015-04-27. The group has the Idylla system to deliver results within a period of between 35 to 150 minutes.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2022
Call Date
Feb 23, 2023
Q4 2022 Earnings Call
No Analysis Available

This earnings call has not been analyzed yet.

If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.

Request Earnings Call Analysis
Other Earnings Calls
2022

Management

Mr. Piet Houwen
Chief Operating Officer
No Bio Available
Mr. Roger Moody
Chief Executive Officer
No Bio Available
Mr. George A. Cardoza
CFO & Head of Service Delivery
No Bio Available
Mr. Benoit Devogelaere
Chief Technology Officer
No Bio Available
Mr. Geert Maertens Ph.D.
Chairman of Scientific Advisory Board & Chief Scientific Officer
No Bio Available
Renate Degrave
Head of IR & Corporate Communications
No Bio Available
Mr. Erik Vossenaar Ph.D.
Senior Vice-President of Corporate Development and Strategy
No Bio Available
Ms. Susy Spruyt
Head of People & Organization
No Bio Available
Dr. Erwin Sablon
Head of R&D and Alliance Management
No Bio Available
Mr. Reginald Van Genechten
Head of Manufacturing & Supply Chain
No Bio Available

Contacts

Address
ANTWERPEN
MALINES (MECHELEN)
Generaal de Wittelaan 11B
Contacts
+3215632600.0
biocartis.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett